These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10906743)

  • 1. Screening and early detection of prostate cancer.
    Schröder FH; Alexander FE; Bangma CH; Hugosson J; Smith DS
    Prostate; 2000 Aug; 44(3):255-63. PubMed ID: 10906743
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.
    Mian BM
    Urol Oncol; 2010; 28(3):233-6. PubMed ID: 20097584
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).
    Bokhorst LP; Zappa M; Carlsson SV; Kwiatkowski M; Denis L; Paez A; Hugosson J; Moss S; Auvinen A; Roobol MJ
    BJU Int; 2016 Nov; 118(5):677-680. PubMed ID: 27104278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
    Schröder FH; Roobol MJ
    BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150
    [No Abstract]   [Full Text] [Related]  

  • 5. Informed consent for PSA testing.
    Brown V
    J Fam Pract; 1996 Sep; 43(3):234-5. PubMed ID: 8797747
    [No Abstract]   [Full Text] [Related]  

  • 6. Perspective: Enforce the clinical guidelines.
    Roobol M
    Nature; 2015 Dec; 528(7582):S123. PubMed ID: 26672782
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection characteristics in randomized prostate screening.
    Schröder FH; Roobol MJ
    Clin Cancer Res; 2004 Sep; 10(17):5641-2. PubMed ID: 15355886
    [No Abstract]   [Full Text] [Related]  

  • 8. Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction.
    Boer R; Schröder FH
    Prostate; 1999 Jul; 40(2):130-4. PubMed ID: 10386474
    [No Abstract]   [Full Text] [Related]  

  • 9. The story of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; Denis LJ; Roobol M; Nelen V; Auvinen A; Tammela T; Villers A; Rebillard X; Ciatto S; Zappa M; Berenguer A; Paez A; Hugosson J; Lodding P; Recker F; Kwiatkowski M; Kirkels WJ;
    BJU Int; 2003 Dec; 92 Suppl 2():1-13. PubMed ID: 14983946
    [No Abstract]   [Full Text] [Related]  

  • 10. Simulated screening for prostate cancer: the useful model.
    Church TR
    J Natl Cancer Inst; 2003 Jun; 95(12):838-9. PubMed ID: 12813160
    [No Abstract]   [Full Text] [Related]  

  • 11. "Screening for prostate cancer".
    Gohagan JK; Kramer BS; Greenwald P
    Am J Prev Med; 1994; 10(4):245-6. PubMed ID: 7528519
    [No Abstract]   [Full Text] [Related]  

  • 12. Two randomized screening trials with prostate cancer mortality, two interim results: a consideration of usual-care window in screening trials.
    Song Y
    Contemp Clin Trials; 2010 Jul; 31(4):378-80. PubMed ID: 20450987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for prostate cancer: an updated Cochrane systematic review.
    Ilic D; O'Connor D; Green S; Wilt TJ
    BJU Int; 2011 Mar; 107(6):882-91. PubMed ID: 21392207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consent before testing men for prostate cancer--a challenge?
    Hirst G
    Aust Fam Physician; 2005 Oct; 34(10):888. PubMed ID: 16217582
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer screening at National Cancer Institute comprehensive and clinical cancer centers.
    Taylor KL; Africano NL; Schwartz M; Cullen J; Ahaghotu C
    J Natl Cancer Inst; 2004 Mar; 96(5):414-5. PubMed ID: 14996868
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for prostate cancer: informing men about their options.
    Mahon SM
    Clin J Oncol Nurs; 2005 Oct; 9(5):625-7. PubMed ID: 16235590
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for prostate cancer: practical analysis of the ERSPC [corrected] and PLCO trials.
    Djavan B
    Eur Urol; 2011 Mar; 59(3):365-9. PubMed ID: 21159418
    [No Abstract]   [Full Text] [Related]  

  • 18. An argument against routine prostate cancer screening.
    Hoffman RM
    Arch Intern Med; 2003 Mar; 163(6):663-5; discussion 665-6. PubMed ID: 12639196
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of a randomized controlled trail of prostate cancer screening.
    Pinsky PF
    Prostate; 2004 Dec; 61(4):371. PubMed ID: 15503321
    [No Abstract]   [Full Text] [Related]  

  • 20. Informed consent for prostate-specific antigen screening.
    Catalona WJ
    Urology; 2003 Jan; 61(1):17-9. PubMed ID: 12559258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.